These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2878065)

  • 1. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 12. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
    Erina EV; Charyev KhE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):26-34. PubMed ID: 6139117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to pindolol administration.
    Gonasun LM; Langrall H
    Am Heart J; 1982 Aug; 104(2 Pt 2):482-6. PubMed ID: 7048882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.